Relay Therapeutics

CHARM Therapeutics

This company develops small-molecule drugs for cancer patients using a deep-learning platform that models protein-ligand interactions to identify novel therapeutic targets.

Remix Therapeutics

This biotechnology company develops small molecule therapies that modulate RNA processing to treat cancers and genetic diseases for patients with unmet medical needs.

Treeline Biosciences

This company develops small molecules and targeted therapies for patients with oncology, immunology and neurology diseases using computational and experimental discovery tools.

Kymera Therapeutics

This biotechnology company develops small molecule medicines that degrade disease-causing proteins for patients with cancer and immune-inflammatory diseases.

Auron Therapeutics

This company develops small-molecule drugs using an AI-powered platform to treat patients with cancer and inflammatory diseases.

Eikon Therapeutics

This biopharmaceutical company develops small molecule medicines for patients with cancer and other serious diseases using a live-cell imaging drug discovery platform.

Skyhawk Therapeutics

This company develops small molecules that modulate RNA for patients with rare neurological, oncological, and autoimmune diseases.

Alterome Therapeutics

This company develops small-molecule targeted therapies for cancer patients by using computational chemistry to address specific genetic mutations.